Share-Based Payments (Tables)
|
12 Months Ended |
Jan. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Option Pricing Assumptions |
The weighted average assumptions used in the Black-Scholes option-pricing model and weighted-average grant date fair value for options granted in 2025, 2024, and 2023 are as follows: | | | | | | | | | | | | | | | | | | | Years Ended | | January 30, 2026 | | January 31, 2025 | | February 2, 2024 | | Weighted-average assumptions used: | | | | | | | Expected volatility | 31.4 | % | | 31.6 | % | | 32.2 | % | | Dividend yield | 1.80 | % | | 1.79 | % | | 1.74 | % | | Risk-free interest rate | 4.03 | % | | 4.33 | % | | 3.59 | % | | Expected term, in years | 7.00 | | 7.00 | | 6.50 | | | | | | | | Weighted-average grant date fair value | $ | 77.51 | | | $ | 84.76 | | | $ | 64.41 | |
|
| Schedule of Stock Option Activity |
Transactions related to stock options for the fiscal year ended January 30, 2026, are summarized as follows: | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands, except per share and years data) | Shares | | Weighted-Average Exercise Price Per Share | | Weighted-Average Remaining Term | | Aggregate Intrinsic Value | | Outstanding as of January 31, 2025 | 1,625 | | | $ | 150.23 | | | | | | | Granted | 138 | | | 234.01 | | | | | | | Canceled, forfeited or expired | (4) | | | 200.43 | | | | | | | Exercised | (181) | | | 115.75 | | | | | | | Outstanding as of January 30, 2026 | 1,578 | | | $ | 161.38 | | | 5.42 | | $ | 166,736 | | Vested and expected to vest as of January 30, 20261 | 1,572 | | | $ | 161.09 | | | 5.41 | | $ | 166,533 | | | Exercisable as of January 30, 2026 | 1,278 | | | $ | 145.59 | | | 4.73 | | $ | 155,227 | |
1 Includes outstanding vested options as well as outstanding nonvested options after a forfeiture rate is applied.
|
| Schedule of Restricted Stock Awards Activity |
Transactions related to restricted stock awards for the fiscal year ended January 30, 2026, are summarized as follows: | | | | | | | | | | | | | (in thousands, except per share data) | Shares | | Weighted-Average Grant-Date Fair Value Per Share | | Nonvested as of January 31, 2025 | 1,277 | | | $ | 224.15 | | | Granted | 764 | | | 234.64 | | | Vested | (567) | | | 215.22 | | | Canceled or forfeited | (119) | | | 232.46 | | | Nonvested as of January 30, 2026 | 1,355 | | | $ | 233.07 | |
|
| Schedule of Awards Granted |
Deferred stock units granted to non-employee Directors in 2025, 2024, and 2023 are as follows: | | | | | | | | | | | | | | | | | | | Years Ended | | (In thousands, except per share data) | January 30, 2026 | | January 31, 2025 | | February 2, 2024 | | Deferred shares granted to non-employee Directors | 11 | | 12 | | 11 | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average grant date fair value per share | $ | 225.73 | | | $ | 221.29 | | | $ | 206.52 | |
|
| Schedule of Performance Share Units Pricing Assumptions |
The weighted-average assumptions used in the Monte Carlo simulations for these awards granted in 2025, 2024, and 2023 are as follows: | | | | | | | | | | | | | | | | | | | Years Ended | | January 30, 2026 | | January 31, 2025 | | February 2, 2024 | | Weighted-average assumptions used: | | | | | | | Expected volatility | 25.4 | % | | 27.1 | % | | 29.3 | % | | Dividend yield | 1.97 | % | | 1.77 | % | | 2.10 | % | | Risk-free interest rate | 3.82 | % | | 4.49 | % | | 3.83 | % | | Expected term, in years | 2.83 | | 2.83 | | 2.82 |
|
| Schedule of Performance Share Units Activity |
Transactions related to performance share units classified as equity awards for the fiscal year ended January 30, 2026, are summarized as follows: | | | | | | | | | | | | | (in thousands, except per share data) | Units1 | | Weighted-Average Grant-Date Fair Value Per Unit | | Nonvested as of January 31, 2025 | 454 | | | $ | 227.46 | | | Granted | 146 | | | 225.57 | | | Vested | (126) | | | 200.06 | | | Canceled or forfeited | (24) | | | 217.78 | | | Nonvested as of January 30, 2026 | 450 | | | $ | 235.07 | |
1 As of January 30, 2026, the maximum number of nonvested units that could vest under the provisions of the agreements was 0.9 million.
|
| Schedule of Restricted Stock Unit Activity |
Transactions related to restricted stock units for the fiscal year ended January 30, 2026, are summarized as follows: | | | | | | | | | | | | | (in thousands, except per share data) | Shares | | Weighted-Average Grant-Date Fair Value Per Share | | Nonvested as of January 31, 2025 | 452 | | | $ | 213.52 | | | Granted | 292 | | | 221.68 | | | Vested | (214) | | | 206.24 | | | Canceled or forfeited | (59) | | | 219.93 | | | Nonvested as of January 30, 2026 | 471 | | | $ | 221.09 | |
|